Monitoring of myelodysplastic syndromes (MDS)

Project objectives

Primary objectives:

• Evaluation of clinical and biological characteristics at diagnosis in patients with MDS

• Evaluation of the clinical course of the disease

• Overall survival

Secondary objectives:

• Analysis of the use of antiblastic or supportive therapy in the various centers and correlation with the diagnostic strategy employed

• Evaluation of the type of treatment and of the therapeutic response in relation to the different WHO and/or IPSS subtypes.

Start and end date

25/03/2010 - ongoing

Project Manager

Prof. Giuseppe Avvisati

Dr. Carolina Nobile

Coordinating institution of the project

UOC Hematology, San Giovanni Addolorata - Rome

Other Institutions involved

• General Hospital Umberto I, University "La Sapienza" - Department of Cellular Biotechnology and Hematology

• Tor Vergata University Hospital (PTV) - Hematology Unit

• Nuova Regina Margherita Hospital - Hematology Division

• Hospital San Giovanni Addolorata - COU of Hematology

• Università Campus Bio-Medico di Roma - Department of Hematology

• Sandro Pertini Hospital - Hematology Unit

• University of Rome "La Sapienza" - Polo Pontino - Division of University Hematology - Latina

• S. Eugenio Hospital - Hematology Division

• Sacro Cuore Catholic University - Hematology Division - Hematology Institute - Agostino Gemelli General Hospital

• San Camillo Forlanini Hospital - Hematology Department

• Sant' HospitalAndrea - University of Rome "La Sapienza" - Second Faculty of Medicine and Surgery - Department of Hematology

• Regina Elena National Cancer Institute